Tevogen Bio Holdings Statistics
Total Valuation
TVGN has a market cap or net worth of $24.19 million. The enterprise value is $31.14 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TVGN has 4.16 million shares outstanding. The number of shares has increased by 13.17% in one year.
| Current Share Class | 4.16M |
| Shares Outstanding | 4.16M |
| Shares Change (YoY) | +13.17% |
| Shares Change (QoQ) | -47.61% |
| Owned by Insiders (%) | 74.58% |
| Owned by Institutions (%) | 2.46% |
| Float | 1.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -133.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -416.53% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 973.40% |
| Weighted Average Cost of Capital (WACC) | 2.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.49M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.72% in the last 52 weeks. The beta is -0.30, so TVGN's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | -88.72% |
| 50-Day Moving Average | 9.89 |
| 200-Day Moving Average | 29.71 |
| Relative Strength Index (RSI) | 40.90 |
| Average Volume (20 Days) | 39,495 |
Short Selling Information
The latest short interest is 85,869, so 2.06% of the outstanding shares have been sold short.
| Short Interest | 85,869 |
| Short Previous Month | 2.92M |
| Short % of Shares Out | 2.06% |
| Short % of Float | 8.11% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.14M |
| Pretax Income | -26.28M |
| Net Income | -26.83M |
| EBITDA | -25.95M |
| EBIT | -26.14M |
| Earnings Per Share (EPS) | -$8.08 |
Full Income StatementBalance Sheet
The company has $552,372 in cash and $7.50 million in debt, with a net cash position of -$6.95 million or -$1.67 per share.
| Cash & Cash Equivalents | 552,372 |
| Total Debt | 7.50M |
| Net Cash | -6.95M |
| Net Cash Per Share | -$1.67 |
| Equity (Book Value) | -8.23M |
| Book Value Per Share | -4.24 |
| Working Capital | -5.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.33 million and capital expenditures -$64,439, giving a free cash flow of -$12.39 million.
| Operating Cash Flow | -12.33M |
| Capital Expenditures | -64,439 |
| Depreciation & Amortization | 190,573 |
| Net Borrowing | 3.40M |
| Free Cash Flow | -12.39M |
| FCF Per Share | -$2.98 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
